XML 24 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Total
Revision of Prior Period, Accounting Standards Update, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Revision of Prior Period, Accounting Standards Update, Adjustment
Accumulated Other Comprehensive Loss
Treasury Stock
Common stock, shares, outstanding, beginning (in shares) at Dec. 31, 2018     17,644,000         7,341,000
Stockholders' equity balance, beginning of the period at Dec. 31, 2018 $ (202,273) $ (5,030) $ 250 $ 237,726 $ 10,414 $ (5,030) $ (60) $ (450,603)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income 76,950       76,950      
Other comprehensive income 0              
Purchase of Company common stock (in shares)     1,067,000         1,067,000
Purchase of Company common stock (90,073)             $ (90,073)
Reissuance of treasury stock (in shares)     (260,000)         (260,000)
Reissuance of treasury stock 10,671   $ (1) (736)       $ 11,408
Net issuance of shares for stock plans (in shares)     (23,000)          
Repurchase of restricted shares for taxes (in shares)     (28,000)          
Repurchase of restricted shares for taxes (2,589)     (2,589)        
Stock-based compensation 8,220     8,220        
Dividends on common stock (35,658)     737 (36,395)      
Common stock, shares, outstanding, ending (in shares) at Sep. 30, 2019     16,786,000         8,148,000
Stockholders' equity balance, ending of the period at Sep. 30, 2019 (239,782)   $ 249 243,358 45,939   (60) $ (529,268)
Common stock, shares, outstanding, beginning (in shares) at Dec. 31, 2018     17,644,000         7,341,000
Stockholders' equity balance, beginning of the period at Dec. 31, 2018 $ (202,273) (5,030) $ 250 237,726 10,414 (5,030) (60) $ (450,603)
Common stock, shares, outstanding, ending (in shares) at Dec. 31, 2019 16,521,921   16,522,000         8,404,000
Stockholders' equity balance, ending of the period at Dec. 31, 2019 $ (241,774) (497) $ 249 246,192 61,653 (497) (58) $ (549,810)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member              
Common stock, shares, outstanding, beginning (in shares) at Jun. 30, 2019     17,252,000         7,697,000
Stockholders' equity balance, beginning of the period at Jun. 30, 2019 $ (215,125)   $ 249 240,555 33,832   (59) $ (489,702)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income 23,917       23,917      
Other comprehensive income (1)           (1)  
Purchase of Company common stock (in shares)     524,000         524,000
Purchase of Company common stock (42,717)             $ (42,717)
Reissuance of treasury stock (in shares)     (73,000)         (73,000)
Reissuance of treasury stock 3,733     582       $ 3,151
Net issuance of shares for stock plans (in shares)     (11,000)          
Repurchase of restricted shares for taxes (in shares)     (4,000)          
Repurchase of restricted shares for taxes (347)     (347)        
Stock-based compensation 2,326     2,326        
Dividends on common stock (11,568)     242 (11,810)      
Common stock, shares, outstanding, ending (in shares) at Sep. 30, 2019     16,786,000         8,148,000
Stockholders' equity balance, ending of the period at Sep. 30, 2019 $ (239,782)   $ 249 243,358 45,939   (60) $ (529,268)
Common stock, shares, outstanding, beginning (in shares) at Dec. 31, 2019 16,521,921   16,522,000         8,404,000
Stockholders' equity balance, beginning of the period at Dec. 31, 2019 $ (241,774) $ (497) $ 249 246,192 61,653 $ (497) (58) $ (549,810)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income (102,433)       (102,433)      
Other comprehensive income 2              
Purchase of Company common stock (in shares)     460,000         460,000
Purchase of Company common stock $ (26,527)             $ (26,527)
Reissuance of treasury stock (in shares) (396,996)   (397,000)         (397,000)
Reissuance of treasury stock $ 20,523     2,658       $ 17,865
Net issuance of shares for stock plans (in shares)     (7,000)          
Repurchase of restricted shares for taxes (in shares)     (35,000)          
Repurchase of restricted shares for taxes (2,438)     (2,438)        
Stock-based compensation 9,193     9,193        
Dividends on common stock (12,208)     507 (12,715)      
Other $ (205)     (205)        
Common stock, shares, outstanding, ending (in shares) at Sep. 30, 2020 16,416,695   16,417,000         8,467,000
Stockholders' equity balance, ending of the period at Sep. 30, 2020 $ (356,364)   $ 249 255,907 (53,992)   (56) $ (558,472)
Common stock, shares, outstanding, beginning (in shares) at Jun. 30, 2020     16,418,000         8,483,000
Stockholders' equity balance, beginning of the period at Jun. 30, 2020 (368,571)   $ 249 254,429 (64,010)   (58) $ (559,181)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income 10,018       10,018      
Other comprehensive income 2           2  
Reissuance of treasury stock (in shares)     (16,000)         (16,000)
Reissuance of treasury stock 0     (709)       $ 709
Net issuance of shares for stock plans (in shares)     (11,000)          
Repurchase of restricted shares for taxes (in shares)     (6,000)          
Repurchase of restricted shares for taxes (309)     (309)        
Stock-based compensation 2,523     2,523        
Other $ (27)     (27)        
Common stock, shares, outstanding, ending (in shares) at Sep. 30, 2020 16,416,695   16,417,000         8,467,000
Stockholders' equity balance, ending of the period at Sep. 30, 2020 $ (356,364)   $ 249 $ 255,907 $ (53,992)   $ (56) $ (558,472)